Literature DB >> 32887713

Novel Monomeric Fungal Subtilisin Inhibitor from a Plant-Pathogenic Fungus, Choanephora cucurbitarum: Isolation and Molecular Characterization.

Duleepa Pathiraja1, Youngeun Chun1, Junghwan Cho1, Byoungnam Min1, Saeyoung Lee1, Hongjae Park1, Juan Byun1, In-Geol Choi2.   

Abstract

The bacterial protease inhibitor domains known as Streptomyces subtilisin inhibitors (SSI) are rarely found in fungi. Genome analysis of a fungal pathogen, Choanephora cucurbitarum KUS-F28377, revealed 11 SSI-like domains that are horizontally transferred and sequentially diverged during evolution. We investigated the molecular function of fungal SSI-like domains of C. cucurbitarum, designated "choanepins." Among the proteins tested, only choanepin9 showed inhibitory activity against subtilisin as the target protease, accounting for 47% of the inhibitory activity of bacterial SSI. However, the binding affinity (expressed as the dissociation constant [Kd ]) of choanepin9 measured via microscale thermophoresis was 21 nM, whereas that for bacterial SSI is 34 nM. The trend of binding and inhibitory activity suggests that the two inhibitors exhibit different inhibitory mechanisms for subtilisin protease. Interestingly, choanepin9 was identified as a monomer in studies in vitro, whereas bacterial SSI is a homodimer. Based on these observations, we constructed a monomeric bacterial SSI protein with decreased binding affinity to abrogate its inhibitory activity. By altering the reactive sites of choanepin9 deduced from the P1 and P4 sites of bacterial SSI, we reestablished that these residues in choanepins are also crucial for modulating inhibitory activity. These findings suggest that the fungal SSI evolved to target specific cognate proteases by altering the residues involved in inhibitory reactivity (reactive sites) and binding affinity (structural integrity). The function of fungal SSI proteins identified in this study provides not only a clue to fungal pathogenesis via protease inhibition but also a template for the design of novel serine protease inhibitors.IMPORTANCE Until recently, Streptomyces subtilisin inhibitors (SSI) were reported and characterized only in bacteria. We found SSI-like domains in a plant-pathogenic fungus, Choanephora cucurbitarum KUS-F28377, which contains 11 sequentially diverged SSI-like domains. None of these fungal SSI-like domains were functionally characterized before. The active form of fungal SSI-like protein is a monomer, in contrast to the homodimeric bacterial SSI. We constructed a synthetic monomer of bacterial SSI to demonstrate the modulation of its activity based on structural integrity and not reactive sites. Our results suggest the duplication and divergence of SSI-like domains of C. cucurbitarum within the genome to inhibit various cognate proteases during evolution by modulating both binding and reactivity. The molecular functional characterization of fungal SSI-like domains will be useful in understanding their biological role and future biotechnological applications.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Choanephora cucurbitarumzzm321990; Streptomyces subtilisin inhibitor; fungal protease inhibitor

Mesh:

Substances:

Year:  2020        PMID: 32887713      PMCID: PMC7642069          DOI: 10.1128/AEM.01818-20

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  37 in total

1.  MUSCLE: multiple sequence alignment with high accuracy and high throughput.

Authors:  Robert C Edgar
Journal:  Nucleic Acids Res       Date:  2004-03-19       Impact factor: 16.971

2.  The complete genome sequence of Escherichia coli DH10B: insights into the biology of a laboratory workhorse.

Authors:  Tim Durfee; Richard Nelson; Schuyler Baldwin; Guy Plunkett; Valerie Burland; Bob Mau; Joseph F Petrosino; Xiang Qin; Donna M Muzny; Mulu Ayele; Richard A Gibbs; Bálint Csörgo; György Pósfai; George M Weinstock; Frederick R Blattner
Journal:  J Bacteriol       Date:  2008-02-01       Impact factor: 3.490

Review 3.  The structural basis of specific protease-inhibitor interactions at the plant-pathogen interface.

Authors:  Anja C Hörger; Renier A L van der Hoorn
Journal:  Curr Opin Struct Biol       Date:  2013-08-09       Impact factor: 6.809

Review 4.  Streptomyces as symbionts: an emerging and widespread theme?

Authors:  Ryan F Seipke; Martin Kaltenpoth; Matthew I Hutchings
Journal:  FEMS Microbiol Rev       Date:  2011-12-02       Impact factor: 16.408

5.  Inhibition of subtilisin BPN' by reaction site P1 mutants of Streptomyces subtilisin inhibitor.

Authors:  S Kojima; Y Nishiyama; I Kumagai; K Miura
Journal:  J Biochem       Date:  1991-03       Impact factor: 3.387

6.  Protease inhibitor from Moringa oleifera with potential for use as therapeutic drug and as seafood preservative.

Authors:  B Bijina; Sreeja Chellappan; Jissa G Krishna; Soorej M Basheer; K K Elyas; Ali H Bahkali; M Chandrasekaran
Journal:  Saudi J Biol Sci       Date:  2011-04-18       Impact factor: 4.219

7.  Refined crystal structure of the complex of subtilisin BPN' and Streptomyces subtilisin inhibitor at 1.8 A resolution.

Authors:  Y Takeuchi; Y Satow; K T Nakamura; Y Mitsui
Journal:  J Mol Biol       Date:  1991-09-05       Impact factor: 5.469

8.  An endogenous target protease, SAM-P26, of Streptomyces protease inhibitor (SSI): primary structure, enzymatic characterization, and its interaction with SSI.

Authors:  S Taguchi; S Yamada; S Kojima; H Momose
Journal:  J Biochem       Date:  1998-10       Impact factor: 3.387

9.  Subtilisin-like proteases in plant-pathogen recognition and immune priming: a perspective.

Authors:  Andreia Figueiredo; Filipa Monteiro; Mónica Sebastiana
Journal:  Front Plant Sci       Date:  2014-12-19       Impact factor: 5.753

10.  Identification and characterization of serine protease inhibitors in a parasitic wasp, Pteromalus puparum.

Authors:  Lei Yang; Yaotian Mei; Qi Fang; Jiale Wang; Zhichao Yan; Qisheng Song; Zhe Lin; Gongyin Ye
Journal:  Sci Rep       Date:  2017-11-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.